Tag: Peginterferon-alfa

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Peginterferon-alfa

Ropeginterferon Alfa-2b Demonstrates Long-Term QOL Improvements in Polycythemia Vera

Added to Collection on: 2022-06-13 19:04:56

Tags for this article:

Medical specialties
Hematopathology
Clinical medicine
Drugs
Antiviral drugs
Ropeginterferon alfa-2b
Polycythemia vera
Polycythemia
Interferon
Myeloproliferative neoplasm
Peginterferon alfa-2b
Peginterferon-alfa

Click the tags to see associated articles and topics

View Article Details
Eiger BioPharmaceuticals Announces Results from Multiple Presentations at the European ...

Added to Collection on: 2022-06-27 20:05:30

Tags for this article:

Medical specialties
Health care
Organic compounds
Hepatitis D
Antiviral drugs
Healthcare-associated infections
Breakthrough therapy
Interferon
Hepatitis
Peginterferon-alfa
Lonafarnib
HDV
eiger biopharmaceuticals inc
Lambda

Click the tags to see associated articles and topics

View Article Details
Eiger BioPharmaceuticals, Inc. (EIGR) CEO David Cory on Q2 2022 Results - Seeking Alpha

Added to Collection on: 2022-08-07 01:04:36

Tags for this article:

Organic compounds
Chemical compounds
Branches of biology
Breakthrough therapy
Chloroarenes
Lonafarnib
Organobromides
Piperidines
Ureas
Hepatitis D
Peginterferon-alfa
Progeria
eiger biopharmaceuticals inc
Lambda
Maurice Raycroft
David Cory Thanks
Ingrid Choong
Sriram Ryali
Jefferies Robert Hazlett
United States
Colleen Craig
David Cory

Click the tags to see associated articles and topics

View Article Details
Eiger Biopharmaceuticals, Inc. (EIGR) Shareholder Alert: - GlobeNewswire

Added to Collection on: 2022-11-12 12:37:07

Tags for this article:

Life Sciences
Articles
Biotechnology
Antivirals
Cytokines
Specialty drugs
Peginterferon-alfa
Interferon
Eiger
Biopharmaceutical
Class action
eiger biopharmaceuticals inc
Lambda

Click the tags to see associated articles and topics

View Article Details
Eiger Biopharmaceuticals, Inc. (EIGR) Shareholder Alert: Robbins LLP Reminds Investors of ...

Added to Collection on: 2022-11-12 16:22:13

Tags for this article:

Life Sciences
Articles
Biotechnology
Antivirals
Cytokines
Specialty drugs
Peginterferon-alfa
Interferon
Eiger
Biopharmaceutical
Class action
eiger biopharmaceuticals inc
Lambda

Click the tags to see associated articles and topics

View Article Details
Eiger Biopharmaceuticals, Inc. (EIGR) Equity Notice: - GlobeNewswire

Added to Collection on: 2022-11-28 23:46:35

Tags for this article:

Life Sciences
Articles
Biotechnology
Antivirals
Cytokines
Specialty drugs
Peginterferon-alfa
Interferon
Eiger
Biopharmaceutical
Class action
eiger biopharmaceuticals inc
Lambda

Click the tags to see associated articles and topics

View Article Details
Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Notifies Eiger BioPharmaceuticals

Added to Collection on: 2022-12-02 15:15:25

Tags for this article:

Peginterferon-alfa

Click the tags to see associated articles and topics

View Article Details
Interferon Beta Drugs Market Advancements Highlighted by Sales Report 2023 - 2032

Added to Collection on: 2024-02-27 14:12:59

Tags for this article:

Cytokines
Interferon beta-1a
Interferon
Management of multiple sclerosis
Multiple sclerosis
Biogen
Peginterferon-alfa
Medication
Roche

Click the tags to see associated articles and topics

View Article Details
Vir Biotechnology (VIR) Up on Positive Data From HDV Study - June 6, 2024 - Zacks.com

Added to Collection on: 2024-06-06 17:32:06

Tags for this article:

Hepatitis D
Peginterferon-alfa
Interferon
Vir Biotechnology Inc.

Click the tags to see associated articles and topics

View Article Details
Ethris shares positive data with mRNA drug following new funding

Added to Collection on: 2024-06-25 16:00:03

Tags for this article:

RNA
Asthma
Chronic lower respiratory diseases
Respiratory therapy
RNA therapeutics
Antiviral drug
Rhinovirus
Interferon
MRNA vaccine
Peginterferon-alfa
Immunoglobulin E
ethris

Click the tags to see associated articles and topics

View Article Details